AlphaYouRS
Insider selling
Ryan Savitz sold $739K of Dianthus Therapeutics, Inc. /DE/ (DNTH) stock
Ryan Savitz, EVP, CFO & Cbo of Dianthus Therapeutics, Inc. /DE/ (DNTH), sold 8,224 shares of DNTH stock worth $739K, per an SEC Form 4 filed Apr 10, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Apr 9, 2026, 1 day before it was made public.
DNTH has moved +5.2% since the trade date, from $91.66 to $96.47 (Sep 21, 2026 close).
- Traded
- Apr 9, 2026
- Disclosed
- Apr 10, 2026
- Filing delay
- 1 day
- Price since
- +5.2%
- Role
- EVP, CFO & Cbo
- Source
- SEC Form 4
More DNTH insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.